A review of dietary supplement-induced renal dysfunction

Clinical Journal of the American Society of Nephrology

Volumn 2, Issue 4, 2007, Pages 757-765

  Gabardi, Steven ^a,b   Munz, Kristin ^a   Ulbricht, Catherine ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE MEDICINE; CHEMICALLY INDUCED DISORDER; DIET SUPPLEMENTATION; HUMAN; IMMUNOLOGY; KIDNEY DISEASE; REVIEW;

COMPLEMENTARY THERAPIES; DIETARY SUPPLEMENTS; HUMANS; KIDNEY DISEASES;

EID: 34548848024     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.00500107     Document Type: Short Survey

References (99)

1. Kessler RC, Davis RB, Foster DF, Van Rompay MI, Walters EE, Wilkey SA, Kaptchuk TJ, Eisenberg DM: Long-term trends in the use of complementary and alternative medical therapies in the United States. Ann Intern Med 135: 262-268, 2001
2. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, Kessler RC: Trends in alternative medicine use in the United States, 1990-1997: Results of a follow-up national survey. JAMA 280: 1569-1575, 1998
3. Clinical practice guidelines in icomplementary and alternative medicine. An analysis of opportunities and obstacles. Practice and Policy Guidelines Panel, National Institutes of Health Office of Alternative Medicine. Arch Fam Med 6: 149-154, 1997
4. NCCAM: Statistics on CAM Use in the United States, Bethesda, NCCAM, 2004. Available at: http://nccam.nih.gov/news/camstats.htm. Accessed January 20, 2007
5. Astin JA: Why patients use alternative medicine: Results of a national study. JAMA 279: 1548-1553, 1998
6. Watson WA, Litovitz TL, Klein-Schwartz W, Rodgers GC Jr, Youniss J, Reid N, Rouse WG, Rembert RS, Borys D: 2003 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 22: 335-404, 2004
7. Food and Drug Administration: Dietary Supplement Health and Education Act (DSHEA) of 1994, Rockville, FDA, 1994. Available at: http:// ww-w.fda.gov/opacom/laws/dshea.html. Accessed January 14, 2007
8. Harris IM: Regulatory and ethical issues with dietary supplements. Pharmacotherapy 20: 1295-1302, 2000
9. Tyler VE: What pharmacists should know about herbal remedies. J Am Pharm Assoc (Wash) NS36: 29-37, 1996
10. Miller LG: Herbal medicinals: Selected clinical considerations focusing on known or potential drug-herb interactions. Arch Intern Med 158: 2200-2211, 1998
11. Scott GN, Elmer GW: Update on natural product-drug interactions. Am J Health Syst Pharm 59: 339-347, 2002
12. Strom BL, Tugwell P: Pharmacoepidemiology: Current status, prospects, and problems. Ann Intern Med 113: 179-181, 1990
13. Leape LL, Brennan TA, Laird N, Lawthers AG, Localio AR, Barnes BA, Hebert L, Newhouse JP, Weiler PC, Hiatt H: The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. N Engl J Med 324: 377-384, 1991
14. Food and Drug Administration: MedWatch Program, Rockville, FDA, 2006. Available at: http://www.fda.gov/medwatch/index.html. Accessed January 16, 2007
15. Cerulli J, Grabe DW, Gauthier I, Malone M, McGoldrick MD: Chromium picolinate toxicity. Ann Pharmacother 32: 428-431, 1998
16. Wasser WG, Feldman NS, D'Agati VD: Chronic renal failure after ingestion of over-the-counter chromium picolinate. Ann Intern Med 126: 410, 1997
17. Wani S, Weskamp C, Marple J, Spry L: Acute tubular necrosis associated with chromium picolinate-containing dietary supplement. Ann Pharmacother 40: 563-566, 2006
18. Koshy KM, Griswold E, Schneeberger EE: Interstitial nephritis in a patient taking creatine. N Engl J Med 340: 814-815, 1999
19. Pritchard NR, Kalra PA: Renal dysfunction accompanying oral creatine supplements. Lancet 351: 1252-1253, 1998
20. Poortmans JR, Auquier H, Renaut V, Durussel A, Saugy M, Brisson GR: Effect of short-term creatine supplementation on renal responses in men. Eur J Appl Physiol Occup Physiol 76: 566-567, 1997
21. Poortmans JR, Francaux M: Long-term oral creatine supplementation does not impair renal function in healthy athletes. Med Sci Sports Exerc 31: 1108-1110, 1999
22. Robinson TM, Sewell DA, Casey A, Steenge G, Greenhaff PL: Dietary creatine supplementation does not affect some haematological indices, or indices of muscle damage and hepatic and renal function. Br J Sports Med 34: 284-288, 2000
23. Nagata N, Yoneyama T, Yanagida K, Ushio K, Yanagihara S, Matsubara O, Eishi Y: Accumulation of germanium in the tissues of a long-term user of germanium preparation died of acute renal failure. J Toxicol Sci 10: 333-341, 1985
24. Luck BE, Mann H, Melzer H, Dunemann L, Begerow J: Renal and other organ failure caused by germanium intoxication. Nephrol Dial Transplant 14: 2464-2468, 1999
25. Schauss AG: Nephrotoxicity in humans by the ultratrace element germanium. Ren Fail 13: 1-4, 1991
26. Takeuchi A, Yoshizawa N, Oshima S, Kubota T, Oshikawa Y, Akashi Y, Oda T, Niwa H, Imazeki N, Seno A, et al.: Nephrotoxicity of germanium compounds: Report of a case and review of the literature. Nephron 60: 436-442, 1992
27. Matsusaka T, Fujii M, Nakano T, Terai T, Kurata A, Imaizumi M, Abe H: Germanium-induced nephropathy: Report of two cases and review of the literature. Clin Nephrol 30: 341-345, 1988
28. Sanai T, Okuda S, Onoyama K, Oochi N, Oh Y, Kobayashi K, Shimamatsu K, Fujimi S, Fujishima M: Germanium dioxide-induced nephropathy: A new type of renal disease. Nephron 54: 53-60, 1990
29. Asaka T, Nitta E, Makifuchi T, Shibazaki Y, Kitamura Y, Ohara H, Matsushita K, Takamori M, Takahashi Y, Genda A: Germanium intoxication with sensory ataxia. J Neurol Sci 130: 220-223, 1995
30. Schauss AG: Nephrotoxicity and neurotoxicity in humans from organogermanium compounds and germanium dioxide. Biol Trace Elem Res 29: 267-280, 1991
31. Obara K, Saito T, Sato H, Yamakage K, Watanabe T, Kakizawa M, Tsukamoto T, Kobayashi K, Hongo M, Yoshinaga K: Germanium poisoning: Clinical symptoms and renal damage caused by long-term intake of germanium. Jpn J Med 30: 67-72, 1991
32. van der Spoel JI, Stricker BH, Esseveld MR, Schipper ME: Dangers of dietary germanium supplements. Lancet 336: 117, 1990
33. Lo JC, Chertow GM, Rennke H, Seifter JL: Fanconi's syndrome and tubulointerstitial nephritis in association with L-lysine ingestion. Am J Kidney Dis 28: 614-617, 1996
34. Smith AY, Feddersen RM, Gardner KD Jr, Davis CJ Jr: Cystic renal cell carcinoma and acquired renal cystic disease associated with consumption of chaparral tea: A case report. J Urol 152: 2089-2091, 1994
35. Evan AP, Gardner KD Jr: Nephron obstruction in nordihydroguaiaretic acid-induced renal cystic disease. Kidney Int 15: 7-19, 1979
36. Goodman T, Grice HC, Becking GC, Salem FA: A cystic nephropathy induced by nordihydroguaiaretic acid in the rat. Light and electron microscopic investigations. Lab Invest 23: 93-107, 1970
37. Sandler B, Aronson P: Yohimbine-induced cutaneous drug eruption, progressive renal failure, and lupus-like syndrome. Urology 41: 343-345, 1993
38. Schmid B, Kotter I, Heide L: Pharmacokinetics of salicin after oral administration of a standardised willow bark extract. Eur J Clin Pharmacol 57: 387-391, 2001
39. Natural Standard: Herbs & Supplements Database, edited by Ulbricht CA, Basch E, Cambridge, MA, Natural Standard, 2007. Available at: http:// www.naturalstandard.com. Accessed December 21, 2006
40. D'Agati V: Does aspirin cause acute or chronic renal failure in experimental animals and in humans? Am J Kidney Dis 28[Suppl 1]: S24-S29, 1996
41. Schwarz A: Beethoven's renal disease based on his autopsy: A case of papillary necrosis. Am J Kidney Dis 21: 643-652, 1993
42. Chou WC, Wu CC, Yang PC, Lee YT: Hypovolemic shock and mortality after ingestion of Tripterygium wilfordii hook F: A case report. Int J Cardiol 49: 173-177, 1995
43. Hilepo JN, Bellucci AG, Mossey RT: Acute renal failure caused by 'cat's claw' herbal remedy in a patient with systemic lupus erythematosus. Nephron 77: 361, 1997
44. Hatch M, Mulgrew S, Bourke E, Keogh B, Costello J: Effect of megadoses of ascorbic acid on serum and urinary oxalate. Eur Urol 6: 166-169, 1980
45. Alkhunaizi AM, Chan L: Secondary oxalosis: A cause of delayed recovery of renal function in the setting of acute renal failure. J Am Soc Nephrol 7: 2320-2326, 1996
46. Friedman AL, Chesney RW, Gilbert EF, Gilchrist KW, Latorraca R, Segar WE: Secondary oxalosis as a complication of parenteral alimentation in acute renal failure. Am J Nephrol 3: 248-252, 1983
47. Lawton JM, Conway LT, Crosson JT, Smith CL, Abraham PA: Acute oxalate nephropathy after massive ascorbic acid administration. Arch Intern Med 145: 950-951, 1985
48. Mashour S, Turner JF Jr, Merrell R: Acute renal failure, oxalosis, and vitamin C supplementation: A case report and review of the literature. Chest 118: 561-563, 2000
49. Ono K: The effect of vitamin C supplementation and withdrawal on the mortality and morbidity of regular hemodialysis patients. Clin Nephrol 31: 31-34, 1989
50. Ponka A, Kuhlback B: Serum ascorbic acid in patients undergoing chronic hemodialysis. Acta Med Scand 213: 305-307, 1983
51. Pru C, Eaton J, Kjellstrand C: Vitamin C intoxication and hyperoxalemia in chronic hemodialysis patients. Nephron 39: 112-116, 1985
52. Swartz RD, Wesley JR, Somermeyer MG, Lau K: Hyperoxaluria and renal insufficiency due to ascorbic acid administration during total parenteral nutrition. Ann Intern Med 100: 530-531, 1984
53. Wong K, Thomson C, Bailey RR, McDiarmid S, Gardner J: Acute oxalate nephropathy after a massive intravenous dose of vitamin C. Aust N Z J Med 24: 410-411, 1994
54. FDA: Evidence on the safety and effectiveness of ephedra: Implications for regulation. 2003. Available at: http://www.fda.gov/bbs/topics/NEWS/ ephedra/whitepaper.html. Accessed January 7, 2006
55. Powell T, Hsu FF, Turk J, Hruska K: Ma-huang strikes again: Ephedrine nephrolithiasis. Am J Kidney Dis 32: 153-159, 1998
56. Blau JJ: Ephedrine nephrolithiasis associated with chronic ephedrine abuse. J Urol 160: 825, 1998
57. Food and Drug Administration: Sales of supplements containing ephedrine alkaloids (ephedra) prohibited, 2004. Available at: http://www.fda.gov/ oc/initiatives/ephedra/february2004/. Accessed January 6, 2007
58. Terris MK, Issa MM, Tacker JR: Dietary supplementation with cranberry concentrate tablets may increase the risk of nephrolithiasis. Urology 57: 26-29, 2001
59. Warren JD, Blumbergs PC, Thompson PD: Rhabdomyolysis: A review. Muscle Nerve 25: 332-347, 2002
60. Weisbord SD, Soule JB, Kimmel PL: Poison on line: Acute renal failure caused by oil of wormwood purchased through the Internet. N Engl J Med 337: 825-827, 1997
61. Kuklo TR, Tis JE, Moores LK, Schaefer RA: Fatal rhabdomyolysis with bilateral gluteal, thigh, and leg compartment syndrome after the Army Physical Fitness Test. A case report. Am J Sports Med 28: 112-116, 2000
62. Robinson SJ: Acute quadriceps compartment syndrome and rhabdomyolysis in a weight lifter using high-dose creatine supplementation. J Am Board Fam Pract 13: 134-137, 2000
63. Sandhu RS, Como JJ, Scalea TS, Betts JM: Renal failure and exercise-induced rhabdomyolysis in patients taking performance-enhancing compounds. J Trauma 53: 761-763, discussion 763-764, 2002
64. Conn JW, Rovner DR, Cohen EL: Licorice-induced pseudoaldosteronism. Hypertension, hypokalemia, aldosteronopenia, and suppressed plasma renin activity. JAMA 205: 492-496, 1968
65. Saito T, Tsuboi Y, Fujisawa G, Sakuma N, Honda K, Okada K, Saito K, Ishikawa S, Saito T: An autopsy case of licorice-induced hypokalemic rhabdornyolysis associated with acute renal failure: Special reference to profound calcium deposition in skeletal and cardiac muscle. Nippon Jinzo Gakkai Shi 36: 1308-1314, 1994
66. Ishikawa S, Kato M, Tokuda T, Momoi H, Sekijima Y, Higuchi M, Yanagisawa N: Licorice-induced hypokalemic myopathy and hypokalemic renal tubular damage in anorexia nervosa. Int J Eat Disord 26: 111-114, 1999
67. Ulbricht C, Basch E, Weissner W, Hackman D: An evidence-based systematic review of herb and supplement interactions by the Natural Standard Research Collaboration. Expert Opin Drug Saf 5: 719-728, 2006
68. Sullivan JB Jr, Rumack BH, Thomas H Jr, Peterson RG, Bryson P: Pennyroyal oil poisoning and hepatotoxicity. JAMA 242: 2873-2874, 1979
69. Bakerink JA, Gospe SM Jr, Dimand RJ, Eldridge MW: Multiple organ failure after ingestion of pennyroyal oil from herbal tea in two infants. Pediatrics 98: 944-947, 1996
70. Mack RB: "Boldly they rode⋯ into the mouth of hell." Pennyroyal oil toxicity. N C Med J 58: 456-457, 1997
71. Anderson IB, Mullen WH, Meeker JE, Khojasteh-BakhtSC, Oishi S, Nelson SD, Blanc PD: Pennyroyal toxicity: Measurement of toxic metabolite levels in two cases and review of the literature. Ann Intern Med 124: 726-734, 1996
72. Sotaniemi E, Hirvonen J, Isomaki H, Takkunen J, Kaila J: Hydrazine toxicity in the human. Report of a fatal case. Ann Clin Res 3: 30-33, 1971
73. Samal KK, Sahu HK, Kar MK, Palit SK, Kar BC, Sahu CS: Yellow oleander (cerbera thevetia) poisoning with jaundice and renal failure. J Assoc Physicians India 37: 232-233, 1989
74. Caldas ED, Machado LL: Cadmium, mercury and lead in medicinal herbs in Brazil. Food Chem Toxicol 42: 599-603, 2004
75. Obi E, Akunyili DN, Ekpo B, Orisakwe OE: Heavy metal hazards of Nigerian herbal remedies. Sci Total Environ 369: 35-41, 2006
76. Bogusz MJ, al Tufail M, Hassan H: How natural are 'natural herbal remedies'? A Saudi perspective. Adverse Drug React Toxicol Rev 21: 219-229, 2002
77. Abt AB, Oh JY, Huntington RA, Burkhart KK: Chinese herbal medicine induced acute renal failure. Arch Intern Med 155: 211-212, 1995
78. Guillaume MP, Peretz A: Possible association between glucosamine treatment and renal toxicity: Comment on the letter by Danao-Camara. Arthritis Rheum 44: 2943-2944, 2001
79. Lord GM, Tagore R, Cook T, Gower P, Pusey CD: Nephropathy caused by Chinese herbs in the UK. Lancet 354: 481-482, 1999
80. Lord GM, Cook T, Arlt VM, Schmeiser HH, Williams G, Pusey CD: Urothelial malignant disease and Chinese herbal nephropathy. Lancet 358: 11515-1516, 2001
81. Nortier JL, Martinez MC, Schmeiser HH, Arlt VM, Bieler CA, Petein M, Depierreux MF, De Pauw L, Abramowicz D, Vereerstraeten P, Vanherweghem JL: Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med 342: 1686-1692, 2000
82. Sabolic I: Common mechanisms in nephropathy induced by toxic metals. Nephron Physiol 104: 107-114, 2006
83. Vanholder R, Cornelis R, Dhondt A, Lameire N: The role of trace elements in uraemic toxicity. Nephrol Dial Transplant 17[Suppl 2]: 2-8, 2002
84. Bourgoin BP, Evans DR, Cornett JR, Lingard SM, Quattrone AJ: Lead content in 70 brands of dietary calcium supplements. Am J Public Health 83: 1155-1160, 1993
85. Ross EA, Szabo NJ, Tebbett IR: Lead content of calcium supplements. JAMA 284: 1425-1429, 2000
86. Grippo AA, Hamilton B, Hannigan R, Gurley BJ: Metal content of ephedra-containing dietary supplements and select botanicals. Am J Health Syst Pharm 63: 635-644, 2006
87. Schaller JL: Mercury and fish oil supplements. MedGenMed 3: 20, 2001
88. Conz PA, La Greca G, Benedetti P, Bevilacqua PA, Cima L: Fucus vesiculosus: A nephrotoxic alga? Nephrol Dial Transplant 13: 526-527, 1998
89. Walkiw O, Douglas DE: Health food supplements prepared from kelp: A source of elevated urinary arsenic. Clin Toxicol 8: 325-331, 1975
90. Segasothy M, Samad S: Illicit herbal preparation containing phenylbutazone causing analgesic nephropathy. Nephron 59: 166-167, 1991
91. Huang WF, Wen KC, Hsiao ML: Adulteration by synthetic therapeutic substances of traditional Chinese medicines in Taiwan. J Clin Pharmacol 37: 344-350, 1997
92. Snyman T, Stewart MJ, Grove A, Steenkamp V: Adulteration of South African traditional herbal remedies. Ther Drug Monit 27: 86-89, 2005
93. Giam YC, Tham SN, Tan T, Lim A: Drug eruptions from phenylbutazone in Jamu. Ann Acad Med Singapore 15: 118-121, 1986
94. Clive DM, Stoff JS: Renal syndromes associated with non-steroidal antiinflammatory drugs. N Engl J Med 310: 563-572, 1984
95. Radford MG Jr, Holley KE, Grande JP, Larson TS, Wagoner RD, Donadio JV, McCarthy JT: Reversible membranous nephropathy associated with the use of nonsteroidal anti-inflammatory drugs. JAMA 276: 466-469, 1996
96. Danao-Camara T: Potential side effects of treatment with glucosamine and chondroitin. Arthritis Rheum 43: 2853, 2000
97. Tyagi A, Delanty N: Herbal remedies, dietary supplements, and seizures. Epilepsia 44: 228-235, 2003
98. Farre M, Xirgu J, Salgado A, Peracaula R, Reig R, Sanz P: Fatal oxalic acid poisoning from sorrel soup. Lancet 2: 1524, 1989
99. Farber SJ, Huertas VE: Intravenously injected marihuana syndrome. Arch Intern Med 136: 337-339, 1976